Comparative assessment of commercial ELISA kits for detection of HIV in India

BMC Research Notes

Table 3 Performance characteristic of HIV ELISA kits used for comparative evaluation

Kit Name & Company	Lot	Kit Performance
		Sensitivity		Specificity		PPV		NPV		Efficiency
		(%)	%Mean (95% CI)	(%)	%Mean (95% CI)	(%)	%Mean (95% CI)	(%)	%Mean (95% CI)	(%)	%Mean (95% CI)
Microlisa HIV Company: J. Mitra & Co. Pvt. Ltd.	1	100	100	100	99.3	100	99.0	100	100	100	99.6
	1	100	(100-100)	100	(98.2-100.3)	100	(97.5-100.4)	100	(100-100)	100	(98.9-100.2)
	2	100		98.3		97.6		100		99.0
	3	100		100		100		100		100
	4	100		98.3		97.6		100		99.0
	5	100		100		100		100		100
Enzaids HIV 1 + 2 ELISA Company: SPAN Diagnostics Ltd.	1	100	100	98.3	99.3	97.6	99.0	100	100	99.0	99.6
	2	100	(100-100)	100	(98.2-100.3)	100	(97.5-100.4)	100	(100-100)	100	(98.9-100.2)
	3	100		100		100		100		100
	4	100		100		100		100		100
	5	100		98.3		97.6		100		99.0
ERBA LISA HIV 1 + 2 Company: Transasia Bio-medicals Ltd.	1	100	100	100	99.6	100	99.5	100	100	100	99.8
	2	100	(100-100)	100	(98.7-100.4)	100	(98.3-100.6)	100	(100-100)	100	(99.3-100.2)
	3	100		100		100		100		100
	4	100		100		100		100		100
	5	100		98.3		97.6		100		99.0
Genscreen Plus HIV Ag-Ab ELISA Company: Bio-Rad Laboratories., U.S.A	1	100	100	96.6	97.2	95.4	96.2	100	100	98.0	98.4
	2	100	(100-100)	96.6	(96.1-98.2)	95.4	(94.8-97.5)	100	(100-100)	98.0	(97.7-99.0)
	3	100		98.3		97.6		100		99.0
	4	100		98.3		97.6		100		99.0
	5	100		96.6		95.4		100		98.0
Vironostika HIV Ag/Ab Company: Biomerieux SA. France	1	100	100	96.6	96.9	95.4	95.8	100	100	98.0	98.2
	2	100	(100-100)	96.6	(95.3-98.4)	95.4	(93.8-97.7)	100	(100-100)	98.0	(97.2-99.1)
	3	100		98.3		97.6		100		99.0
	4	100		95.0		93.4		100		97.0
	5	100		98.3		97.6		100		99.0

ISSN: 1756-0500